JKT-1 is not a human seminoma cell line. 2007

Jeroen de Jong, and Hans Stoop, and Ad J M Gillis, and Ruud J H L M van Gurp, and Ellen van Drunen, and H Berna Beverloo, and Yun-Fai Chris Lau, and Dominik T Schneider, and Jon K Sherlock, and John Baeten, and Shingo Hatakeyama, and Chikara Ohyama, and J Wolter Oosterhuis, and Leendert H J Looijenga
Department of Pathology, Erasmus MC-University Medical Center Rotterdam, Josephine Nefkens Institute, Daniel den Hoed Cancer Center.

The JKT-1 cell line has been used in multiple independent studies as a representative model of human testicular seminoma. However, no cell line for this specific tumour type has been independently confirmed previously; and therefore, the seminomatous origin of JKT-1 must be proven. The genetic constitution of the JKT-1 cells was determined using flow cytometry and spectral karyotyping, as well as array comparative genomic hybridization and fluorescent in situ hybridization. Marker profiling, predominantly based on differentially expressed proteins during normal germ cell development, was performed by immunohistochemistry and Western blot analyses. Moreover, genome wide affymetrix mRNA expression and profiling of 157 microRNAs was performed, and the status of genomic imprinting was determined. A germ cell origin of the JKT-1 cells was in line with genomic imprinting status and marker profile (including positive staining for several cancer-testis antigens). However, the supposed primary tumour, from which the cell line was derived, being indeed a classical seminoma, was molecularly proven not to be the origin of the cell line. The characteristic chromosomal anomalies of seminoma, e.g. gain of the short arm of chromosome 12, as well as the informative marker profile (positive staining for OCT3/4, NANOG, among others) were absent in the various JKT-1 cell lines investigated, irrespective of where the cells were cultured. All results indicate that the JKT-1 cell line is not representative of human seminoma. Although it can originate from an early germ cell, a non-germ cell derivation cannot be excluded.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D008297 Male Males
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013736 Testicular Neoplasms Tumors or cancer of the TESTIS. Germ cell tumors (GERMINOMA) of the testis constitute 95% of all testicular neoplasms. Cancer of Testis,Cancer of the Testes,Testicular Cancer,Testicular Neoplasm,Testicular Tumor,Testis Cancer,Cancer of the Testis,Neoplasms, Testicular,Neoplasms, Testis,Testicular Tumors,Testis Neoplasms,Tumor of Rete Testis,Cancer, Testicular,Cancer, Testis,Cancers, Testicular,Cancers, Testis,Neoplasm, Testicular,Neoplasm, Testis,Rete Testis Tumor,Rete Testis Tumors,Testicular Cancers,Testis Cancers,Testis Neoplasm,Testis Tumor, Rete,Testis Tumors, Rete,Tumor, Testicular,Tumors, Testicular
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D018239 Seminoma A radiosensitive, malignant neoplasm of the testis, thought to be derived from primordial germ cells of the sexually undifferentiated embryonic gonad. There are three variants: classical (typical), the most common type; anaplastic; and spermatocytic. The classical seminoma is composed of fairly well differentiated sheets or cords of uniform polygonal or round cells (seminoma cells), each cell having abundant clear cytoplasm, distinct cell membranes, a centrally placed round nucleus, and one or more nucleoli. In the female, a grossly and histologically identical neoplasm, known as dysgerminoma, occurs. (Dorland, 27th ed) Seminomas

Related Publications

Jeroen de Jong, and Hans Stoop, and Ad J M Gillis, and Ruud J H L M van Gurp, and Ellen van Drunen, and H Berna Beverloo, and Yun-Fai Chris Lau, and Dominik T Schneider, and Jon K Sherlock, and John Baeten, and Shingo Hatakeyama, and Chikara Ohyama, and J Wolter Oosterhuis, and Leendert H J Looijenga
May 1998, International journal of urology : official journal of the Japanese Urological Association,
Jeroen de Jong, and Hans Stoop, and Ad J M Gillis, and Ruud J H L M van Gurp, and Ellen van Drunen, and H Berna Beverloo, and Yun-Fai Chris Lau, and Dominik T Schneider, and Jon K Sherlock, and John Baeten, and Shingo Hatakeyama, and Chikara Ohyama, and J Wolter Oosterhuis, and Leendert H J Looijenga
February 2010, International journal of andrology,
Jeroen de Jong, and Hans Stoop, and Ad J M Gillis, and Ruud J H L M van Gurp, and Ellen van Drunen, and H Berna Beverloo, and Yun-Fai Chris Lau, and Dominik T Schneider, and Jon K Sherlock, and John Baeten, and Shingo Hatakeyama, and Chikara Ohyama, and J Wolter Oosterhuis, and Leendert H J Looijenga
February 2008, Cell and tissue research,
Jeroen de Jong, and Hans Stoop, and Ad J M Gillis, and Ruud J H L M van Gurp, and Ellen van Drunen, and H Berna Beverloo, and Yun-Fai Chris Lau, and Dominik T Schneider, and Jon K Sherlock, and John Baeten, and Shingo Hatakeyama, and Chikara Ohyama, and J Wolter Oosterhuis, and Leendert H J Looijenga
March 1999, BJU international,
Jeroen de Jong, and Hans Stoop, and Ad J M Gillis, and Ruud J H L M van Gurp, and Ellen van Drunen, and H Berna Beverloo, and Yun-Fai Chris Lau, and Dominik T Schneider, and Jon K Sherlock, and John Baeten, and Shingo Hatakeyama, and Chikara Ohyama, and J Wolter Oosterhuis, and Leendert H J Looijenga
February 2013, Urology,
Jeroen de Jong, and Hans Stoop, and Ad J M Gillis, and Ruud J H L M van Gurp, and Ellen van Drunen, and H Berna Beverloo, and Yun-Fai Chris Lau, and Dominik T Schneider, and Jon K Sherlock, and John Baeten, and Shingo Hatakeyama, and Chikara Ohyama, and J Wolter Oosterhuis, and Leendert H J Looijenga
February 1981, Journal of clinical pathology,
Jeroen de Jong, and Hans Stoop, and Ad J M Gillis, and Ruud J H L M van Gurp, and Ellen van Drunen, and H Berna Beverloo, and Yun-Fai Chris Lau, and Dominik T Schneider, and Jon K Sherlock, and John Baeten, and Shingo Hatakeyama, and Chikara Ohyama, and J Wolter Oosterhuis, and Leendert H J Looijenga
November 1981, Journal of clinical pathology,
Jeroen de Jong, and Hans Stoop, and Ad J M Gillis, and Ruud J H L M van Gurp, and Ellen van Drunen, and H Berna Beverloo, and Yun-Fai Chris Lau, and Dominik T Schneider, and Jon K Sherlock, and John Baeten, and Shingo Hatakeyama, and Chikara Ohyama, and J Wolter Oosterhuis, and Leendert H J Looijenga
March 1988, Science (New York, N.Y.),
Jeroen de Jong, and Hans Stoop, and Ad J M Gillis, and Ruud J H L M van Gurp, and Ellen van Drunen, and H Berna Beverloo, and Yun-Fai Chris Lau, and Dominik T Schneider, and Jon K Sherlock, and John Baeten, and Shingo Hatakeyama, and Chikara Ohyama, and J Wolter Oosterhuis, and Leendert H J Looijenga
September 1985, Proceedings of the National Academy of Sciences of the United States of America,
Jeroen de Jong, and Hans Stoop, and Ad J M Gillis, and Ruud J H L M van Gurp, and Ellen van Drunen, and H Berna Beverloo, and Yun-Fai Chris Lau, and Dominik T Schneider, and Jon K Sherlock, and John Baeten, and Shingo Hatakeyama, and Chikara Ohyama, and J Wolter Oosterhuis, and Leendert H J Looijenga
January 1994, Investigative urology (Berlin, Germany),
Copied contents to your clipboard!